XtalPi has developed a breakthrough Twin-Star molecular formula using AI, which activates follicle stem-cell pathways to promote rapid hair growth, and is ready for licensing, co-development, or ingredient evaluation.
XtalPi Holdings Limited has created a Twin-Star topical molecular formula, Remeanagen™ (XTP-118) and AquaKine™ (XTP-016), using their AI-driven molecular design platform. These ingredients activate follicle stem-cell pathways, increase hair density quickly, and have obtained international registration and FDA listing, making them suitable for licensing, co-development, or ingredient evaluation collaborations, especially with companies like Henkel. The technology demonstrates efficacy, safety, and rapid onset, with a strong market potential.